Tuberculin reaction, BCG scar, and lower female mortality

Epidemiology

Volumn 17, Issue 5, 2006, Pages 562-568

  Roth, Adam ^a   Sodemann, Morten ^b   Jensen, Henrik ^a   Poulsen, Anja ^a   Gustafson, Per ^c   Weise, Christian ^b   Gomes, Justino ^b   Djana, Queba ^b   Jakobsen, Marianne ^b   Garly, May Lill ^a   Rodrigues, Amabelia ^b   Aaby, Peter ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b Bandim Health Project   (Denmark)

^c Infectious Diseases Research Group   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; COHORT ANALYSIS; DRUG RESPONSE; FEMALE; GENDER; GUINEA-BISSAU; HEALTH CARE POLICY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SKIN SCAR; SURVIVAL RATE; SURVIVAL TIME; TUBERCULIN TEST; TUBERCULOSIS;

BCG VACCINE; COHORT STUDIES; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; MALE; SEX FACTORS; TUBERCULIN TEST;

EID: 33747089946     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000231546.14749.ab     Document Type: Article

References (40)

1. Orme IM. Beyond BCG: the potential for a more effective TB vaccine. Mol Med Today. 1999;5:487-492.
2. Comstock GW. Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials. 1994;15:247-276.
3. Kristensen I, Aaby P, Jensen H. Routine immunizations and child survival in Guinea-Bissau, West-Africa. BMJ. 2000;321:1435-1438.
4. Velema JP, Alihonou EM, Gandaho T, et al. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol. 1991;20:474-479.
5. Niobey FM, Duchiade MP, Vasconcelos AG, et al. [Risk factors for death caused by pneumonia in children younger than 1 year old in a metropolitan region of southeastern Brazil. A case-control study]. Rev Saude Publica. 1992;26:229-238.
6. Aaby P, Jensen H. Routine vaccinations and child survival: effect of gender. BMJ. 2002 December 13. Available at: bmj.com/cgi/eletters/321/7274/ 1435#27803.
7. Aaby P, Jensen H, Rodrigues A, et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol. 2004;33:367-373.
8. Stensballe LG, Nante E, Jensen IP, et al. BCG vaccination, acute lower respiratory tract infections, and respiratory syncytial virus in children in Guinea-Bissau: a beneficial effect for girls. Vaccine. 2005;23:1251-1257.
9. Mackaness GB. The immunology of antituberculous immunity. Am Rev Respir Dis. 1968;97:337-344.
10. Matsumoto S, Yukitake H, Kanbara H, et al. Mycobacterium bovis bacillus Calmette-Guerin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection. Vaccine. 2000;19:779 -787.
11. Garly ML, Bale C, Martins CL, et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine. 2001;20:468-474.
12. Aaby P, Shaheen S, Heyes C, et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy. 2000;30:644-650.
13. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol. 1999;163:2249 -2255.
14. Roth A, Sodemann M, Jensen H, et al. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine. 2005;23:3991-3998.
15. Garly ML, Martins CL, Bale C, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West-Africa. A nonspecific beneficial effect of BCG? Vaccine. 2003;21:2782-2790.
16. Roth A, Gustafson P, Nhaga A, et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol. 2005;34:540-547.
17. Bouros D, Zeros G, Panaretos C, et al. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest. 1991;99:416-419.
18. Gustafson P, Gomes VF, Vieira CS, et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol. 2004;33:163-172.
19. Enarson DA, Rieder HL, Arnadottir T, et al. Management of Tuberculosis. A Guide for Low Income Countries, 5th ed. Paris: International Union Against Tuberculosis and Lung Disease; 2000.
20. Jensen H, Benn CS, Aaby P. DTP in low income countries: improved child survival or survival bias? BMJ. 2005;330:845-846.
21. Floyd S, Ponnighaus JM, Bliss L, et al. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis. 2002;186:807-814.
22. Aronson JD. Protective vaccination against tuberculosis with special reference to BCG vaccination. Am Rev Tuberc. 1948;58:255-281.
23. MRC. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescents. BMJ. 1959;2:369-396.
24. Aaby P, Jensen H, Gomes J, et al. The introduction of diththeria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol. 2004;33:374-380.
25. Aaby P, Jensen H, Garly ML, et al. Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine. 2002;21:15-20.
26. BCG vaccination and pediatric HIV infection - Rwanda, 1988-1990. MMWR Morb Mortal Wkly Rep. 1991;40:833-836.
27. Lallemant-Le Coeur S, Lallemant M, Cheynier D, et al. Bacillus Calmette-Guerin immunisation in infants born to HIV-1 seropositive mothers. AIDS. 1991;5:195-199.
28. Ota MO, O'Donovan D, Marchant A, et al. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a bacillus Calmette-Guerin scar. AIDS. 1999;13:996-998.
29. Raszka WV, Moriarty RA, Ottolini MG, et al. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients. J Pediatr. 1996;129:245-250.
30. Poulsen AG, Kvinesdal B, Aaby Peal. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet. 1989;1:827-831.
31. Larsen O, da Silva Z, Sandstrom A, et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS. 1998;12:1707-1714.
32. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-A and HIV-2 in Abidjan, Ivory Coast. JAMA. 1994;272:462-466.
33. Prazuck T, Yameogo JM, Heylinck B, et al. Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J. 1995;14:940-947.
34. Almeida LM, Barbieri MA, Da Paixao AC, et al. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J. 2001;20:1061-1065.
35. Beyers N, Gie RP, Schaaf HS, et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis. 1997;1:38-43.
36. Lockman S, Tappero JW, Kenyon TA, et al. Tuberclin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis. 1999;3:23-30.
37. Aaby P, Samb B, Simondon F, et al. Divergent mortality for male and female recipients of lowtitre and hightitre measles vaccines in rural Senegal. Am J Epidemiol. 1993;138:746-755.
38. Aaby P, Garly ML, Balé C, et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. PIDJ. 2003;22:798-805.
39. Desgrees du LA, Pison G, Aaby P. Role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. Am J Epidemiol. 1995;142:643-652.
40. Aaby P, Jensen H, Samb B, et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet. 2003;361:2183-2188.